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CLINICAL SCIENCES
Subjective Quality of Vision Before and After
Cataract Surgery
Eirini Skiadaresi, MD; Colm McAlinden, PhD; Konrad Pesudovs, PhD;
Silvio Polizzi, MD; Jyoti Khadka, PhD; Giuseppe Ravalico, MD
Objective: To investigate the effect of cataract surgery
on subjective quality of vision.
Methods: The Quality of Vision (QoV) questionnaire
(Italian translation) was completed before and 3 months
after cataract surgery in 4 groups of patients recruited
from September through December 2010: first eye with
ocular comorbidity, first eye without ocular comorbid-
ity, second eye with ocular comorbidity, and second eye
without ocular comorbidity. The questionnaire mea-
sures 3 aspects of quality of vision: frequency, severity,
and bothersome nature of symptoms. The Lens Opaci-
ties Classification System (LOCS) III was used for cata-
ract grading. Friedman and Kruskal-Wallis H tests were
performed to compare QoV scores within and between
groups. Spearman rank correlations (rs) were calculated
to investigate the correlation between LOCS III and QoV
symptoms.
Results: Two hundred twelve patients (mean [SD] age,
74.2 [8.7] years) were recruited, and 212 eyes were in-
cluded in the study. Improvements in QoV scores were
found in all 4 groups (P .05). There were no statistically
significant (P .05) differences among the 4 groups in the
improvement in QoV scores or in the preoperative or post-
operative scores. Blurred vision was correlated with pos-
terior subcapsular cataract (rs=0.420, P=.04).
Conclusions: Cataract in one or both eyes causes a simi-
lar loss in subjective quality of vision, which is also irre-
spective of the presence of ocular comorbidity. Posterior
subcapsular cataract causes the specific symptom “blurred
vision.” Cataract surgery resulted in a large and compa-
rable improvement in subjective quality of vision, regard-
less of ocular comorbidity and first or second eye surgery.
Arch Ophthalmol. 2012;130(11):1377-1382
C ATARACT SURGERY IS ONEof the most commonlyperformed surgical pro-cedures worldwide.1There have been con-
stant improvements in surgical tech-
niques and equipment, resulting in fewer
complications and quicker visual recov-
ery.2 Concurrently, patient expectation and
the role of refractive error as both indica-
tion and outcome have increased.
Most studies3 evaluating cataract sur-
gery outcomes have focused on visual acu-
ity and refractive status. Such objective mea-
sures are useful but may fail to highlight
important patient perceptions, such as qual-
ity of vision (eg, glare and haloes), which
may be present despite good visual acuity
and minimal refractive error. A number of
questionnaires have been developed and
validated to provide a direct measure of sub-
jective outcomes of cataract surgery. These
questionnaires can measure a number of dif-
ferent traits, such as visual symptoms with
the Quality of Vision (QoV) question-
naire,4 visual functioning with the Visual
Function Index–14,5 and visual function-
ing and socioemotional status with the
National Eye Institute Visual Function
Questionnaire.6
The QoV questionnaire was recently de-
veloped to provide a patient-reported mea-
sure of quality of vision across a range of
groups, including refractive correction (re-
fractive surgery, spectacles, and contact
lenses) and cataract. The questionnaire
uses photographs to simulate visual symp-
toms, with patients reporting how often
they experience the symptom (fre-
quency), how severely they experience the
symptom (severity), and how bothered
they are by the symptom (bothersome).
The questionnaire was developed, vali-
dated, and scored using Rasch analysis. Ra-
sch analysis enables an in-depth assess-
ment of the psychometric properties of the
questionnaire, and it estimates interval-
scaled measures from ordinal data. This
analysis overcomes the disadvantages of
simple summary scoring, which incor-
rectly assumes that the quantitative dif-
ference between each response option is
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equal and that each question has the same value.7 It im-
proves measurement precision, which has been demon-
strated in cataract surgery outcome studies.8,9 Rasch analy-
sis is based on a probabilistic relationship between item
difficulty and person ability (functional reserve). This
analysis expresses the probability of any person being suc-
cessful on any item with a polytomous Andrich rating
scale model (ln[p(x)/p(x − 1)]), which is often used for
multiple options. For each individual, rating scale re-
sponses are mutually exclusive. So, if person n re-
sponded to item i with rating category x or x − 1, then
the posterior probability (p) of that person responding
with any other rating category is 0.10
Cataract surgery has been convincingly demon-
strated to provide significant improvements in objective
measurements and subjective improvements in quality
of life and visual functioning.11 What has been less thor-
oughly studied is the improvement in visual symptoms,
such as glare and haloes, after cataract surgery. The
purpose of this prospective study was to investigate the
change in subjective quality of vision after cataract sur-
gery using the QoV questionnaire in patients undergo-
ing first eye and second eye cataract surgery with or
without ocular comorbidity. A secondary purpose was
to investigate the correlation between preoperative
visual symptoms and cataract morphology to determine
which symptoms are predictive of different types of
cataract.
METHODS
PATIENTS
In this prospective cohort study, consecutive patients under-
going cataract surgery by phacoemulsification and monofo-
cal intraocular lens (IOL) implantation at an ophthalmology
department in an Italian public hospital were invited to par-
ticipate. Patients were recruited using standard informed
consent procedures from September to December 2010.
Patients completed an Italian-translated version of the QoV
questionnaire via interview with an ophthalmologist before
and at 3 months after cataract surgery. A 3-month period
was chosen to enable patients to acquire refractive correc-
tion in the form of spectacles if needed and to enable a sig-
nificant adaptation period to their new refractive correction
and quality of vision. Patients were advised to obtain new
spectacle correction approximately 6 weeks postoperatively.
All patients in this study had only 1 eye operated on, and in
the case of first eye surgery, the eye operated on had the
worst visual acuity. All operations were performed by the
same experienced cataract surgeon in the same center, and
each patient was consecutive. The tenets of the Declaration
of Helsinki were followed, and the study was approved by
the University of Trieste Medical Ethics Committee.
Exclusion criteria consisted of poor comprehension of writ-
ten or spoken Italian language and vulnerable patient groups.
Patients with ocular comorbidity were not excluded to pro-
vide a representative sample of patients undergoing cataract sur-
gery. Ocular comorbidity was defined as the presence of any po-
tentially visually significant eye disease other than cataract even
in a mild form. Data were collected for single eye surgery (first
or second eye surgery) to ensure statistical independence. All
study participants were 18 years or older and signed a consent
form.
THE QoV QUESTIONNAIRE
The QoV questionnaire enables the measurement of subjec-
tive quality of vision. The QoV questionnaire consists of a 10-
item instrument with 3 subscales, providing a QoV score in terms
of frequency, severity, and bothersome nature of the follow-
ing symptoms: glare, haloes, starbursts, hazy vision, blurred vi-
sion, distortion, double or multiple images, fluctuation in vi-
sion, focusing difficulties, and depth perception difficulties. The
first 7 symptoms have an associated image to simulate the symp-
tom for easier understanding. Rasch scaling is used with logits
converted to a 0- to 100-unit linear scale, with higher scores
indicating poorer quality of vision.
TRANSLATION OF THE QoV QUESTIONNAIRE
FROM ENGLISH TO ITALIAN
The translation team consisted of a coordinator, an Italian oph-
thalmologist fluent in English, a professional native Italian-
speaking translator, and 2 professional native English-speaking
translators. Initially, 2 forward translations were produced by 2
independent native Italian speakers. The 2 translators met with
the coordinator to produce a reconciled Italian version. The ques-
tionnaire was then back translated in an independent manner by
2 native professional English-speaking translators. Subse-
quently, the translating team met, and the reconciled forward trans-
lation was revised according to the review of the back transla-
tions. Pilot testing of the target version was then conduced to verify
understanding of the questionnaire.
CLINICAL EXAMINATION
Each participant underwent a comprehensive eye examination,
before and 3 months after cataract surgery, by an experienced oph-
thalmologist. In addition to completion of the QoV question-
naire, uncorrected distance visual acuity (UDVA) in log mini-
mum angle of resolution (logMAR), spherical equivalent subjective
refraction, logMAR corrected distance visual acuity (CDVA), and
Lens Opacities Classification System (LOCS) III grading of cata-
ract were recorded for each eye.12 The LOCS III cataract severity
was graded on a decimal scale for each of the 4 possible compo-
nents: nuclear opalescence, nuclear color, cortical component,
and posterior subcapsular component. For each cataract type or
for nuclear color, higher grading scores indicate greater severity.
The scale ranges from 0.1 (clear or colorless) to 5.9 (very opaque
in cases of cortical and posterior subcapsular) or 6.9 (very opaque
or brunescent in cases of opalescence and nuclear color). Biom-
etry was performed using the IOL Master 500 (Carl Zeiss Medi-
tec AG), and the target refractive error was 0 in all patients. Pa-
tients underwent standard phacoemulsification cataract surgery
and monofocal IOL implantation. Standard demographic data were
collected for each patient, including age and sex. The median and
range of preoperative and postoperative QoV scores, logMAR
UDVA, spherical equivalent subjective refraction, and logMAR
CDVA were calculated.
STATISTICAL ANALYSIS
Patients were divided into 4 groups: first eye with ocular co-
morbidity, first eye without ocular comorbidity, second eye with
ocular comorbidity, and second eye without ocular comorbid-
ity. Data were assessed for normality using the Shapiro-Wilk
test, which found QoV scores, LOCS III grade, visual acuity,
and refraction to be nonnormally distributed. Friedman tests
were performed to determine statistical significance of preop-
erative to postoperative changes within each group. Kruskal-
Wallis H tests were performed to determine whether the pre-
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operative and postoperative QoV scores and changes in scores
among the 4 groups were statistically significantly different.
To determine the correlation between each LOCS III grad-
ing and the frequency of QoV symptoms, patients were grouped
by their respective cataract morphology: nuclear, cortical, or
posterior subcapsular (using the LOCS III grading). The cut-
off for nuclear and cortical cataract was 2.5, and the cutoff for
posterior subcapsular was 0.1, in line with previous studies.13
Therefore, a nuclear cataract was defined as a LOCS III grad-
ing greater than 2.5 for nuclear opalescence, 2.5 or less for the
cortical component, and 0.1 or less for the posterior subcap-
sular component. Similarly, a cortical cataract was defined as a
LOCS III grading of greater than 2.5 for the cortical compo-
nent, 2.5 or less for nuclear opalescence, and 0.1 or less for the
posterior subcapsular component. Posterior subcapsular cata-
racts were defined as a LOCS III grading greater than 0.1 for
the posterior subcapsular component and 2.5 or less for nuclear
opalescence and the cortical component. Mixed cataracts were
excluded from the analysis. Spearman rank correlation coeffi-
cients (rs) were calculated.14 A strong correlation was classi-
fied as a coefficient greater than 0.8, moderately strong within
the range of 0.5 to 0.8, fair within the range of 0.3 to 0.5, and
poor at less than 0.3.15 All statistics were calculated using SPSS
statistical software (SPSS Inc) and Excel (Microsoft). P.05 was
considered statistically significant in all statistical tests.
RESULTS
Two hundred twelve patients (mean [SD] age, 74.2 [8.7]
years) were recruited, and 212 eyes were included in the
study. Three patients had complicated surgery (capsu-
lar tear and anterior vitrectomy) and were excluded from
the analysis, leaving 209 eyes of 209 patients. The stan-
dard demographics of the 4 groups in the study popula-
tion are listed in Table 1. A statistically significant im-
provement was seen in UDVA and CDVA in all 4 groups
and in spherical equivalent refraction in all groups ex-
cept for patients who underwent first eye cataract sur-
gery with ocular comorbidity (Table 2).
A statistically significant improvement was seen in QoV
scores for frequency, severity, and bothersome nature of
symptoms in all 4 groups of patients (Figure). Kruskal-
Wallis H tests found no statistically significant differ-
ences in the improvement in the QoV questionnaire sub-
scale among the 4 groups (Table 3). No statistically
significant differences were found in the preoperative and
postoperative QoV scores in each group. A poor corre-
lation was found between the change in CDVA and QoV
Table 1. Preoperative Demographic Data and Cataract Grading With the Lens Opacities Classification System III of the 209 Patients
in the Study Populationa
Characteristic
First Eye (n = 106) Second Eye (n = 103)
Without Comorbidity
(n = 78)
With Comorbidity
(n = 28)
Without Comorbidity
(n = 78)
With Comorbidity
(n = 25)
Male/female, No.b 33/45 15/13 30/48 9/16
Age, mean (SD), yc 72.6 (8.9) 75.0 (8.6) 75.2 (9.0) 75.3 (6.7)
Nuclear opalescence 4.15 (4.00) 4.95 (5.79) 4.75 (4.90) 4.55 (4.10)
Nuclear color 4.05 (4.50) 4.50 (4.50) 4.55 (3.60) 5.00 (4.30)
Cortical 2.70 (4.00) 2.70 (5.40) 2.85 (4.20) 2.60 (4.00)
Posterior subcapsular 0.10 (4.80) 1.55 (5.80) 0.10 (4.40) 0.75 (4.60)
aData are presented as median (range) unless otherwise indicated.
bFemales and males were not equally distributed across groups (P = .004, 2 test).
cMean age was comparable across questionnaires (P  .05, analysis of variance).
Table 2. Mean (Range) Preoperative and Postoperative QoV Scores, LogMAR UDVA, Spherical Equivalent Refraction, and LogMAR
CDVA in Patients Undergoing First and Second Eye Cataract Surgery With and Without Comorbidity
Variable
Without Comorbidity With Comorbidity
Preoperative Postoperative 2 (P Value) Preoperative Postoperative 2 (P Value)
First eye
Frequency QoV score 41.00 (87.00) 15.00 (72.00) 32.014 (.001) 41.00 (77.00) 15.00 (90.00) 9.00 (.003)
Severity QoV score 35.00 (70.00) 13.00 (66.00) 25.657 (.001) 35.00 (70.00) 6.50 (86.00) 9.00 (.003)
Bothersome QoV score 34.00 (85.00) 0.00 (75.00) 18.846 (.001) 26.00 (85.00) 7.00 (88.00) 8.17 (.004)
LogMAR UDVA 0.70 (1.22) 0.26 (1.00) 69.208 (.001) 1.00 (2.50) 0.28 (1.25) 24.14 (.001)
Spherical equivalent −0.75 (9.98) −0.50 (2.38) 16.615 (.001) 0.00 (13.25) −0.56 (2.50) 3.57 (.06)
LogMAR CDVA 0.35 (0.78) 0.05 (0.40) 68.211 (.001) 0.52 (2.68) 0.05 (1.00) 27.00 (.001)
Second eye
Frequency QoV score 41.00 (90.00) 0.00 (72.00) 32.143 (.001) 45.00 (75.00) 25.00 (69.00) 8.909 (.003)
Severity QoV score 32.00 (78.00) 0.00 (52.00) 31.226 (.001) 35.00 (68.00) 22.00 (57.00) 11.636 (.001)
Bothersome QoV score 29.00 (93.00) 0.00 (63.00) 28.452 (.001) 34.00 (78.00) 0.00 (73.00) 5.261 (.02)
LogMAR UDVA 0.85 (2.75) 0.30 (1.00) 60.842 (.001) 1.00 (2.70) 0.26 (1.00) 17.190 (.001)
Spherical equivalent 0.00 (8.75) −0.57 (4.50) 6.205 (.01) −0.63 (10.75) 0.00 (5.50) 4.167 (.04)
LogMAR CDVA 0.30 (2.80) 0.00 (1.04) 74.0 (.001) 0.40 (2.85) 0.15 (1.04) 12.565 (.001)
Abbreviations: CDVA, corrected distance visual acuity; logMAR, logarithmic minimum angle of resolution; QoV, Quality of Vision; UDVA, uncorrected distance
visual acuity.
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scores (frequency subscale) for patients who under-
went second eye cataract surgery without ocular comor-
bidity (rs = 0.298;P = .008). All other comparisons yielded
no statistically significant differences (first eye without
ocular comorbidity, r = 0.114, P = .32; first eye with ocu-
lar comorbidity, r = 0.247, P = .21; second eye with ocu-
lar comorbidity, r = −0.166, P = .44).
Each of the 4 groups of patients had greater levels
of nuclear than cortical or posterior subcapsular cata-
racts (Table 1). With all patients grouped together, there
were 24 eyes with nuclear cataract, 25 eyes with poste-
rior subcapsular cataract, and 3 eyes with cortical cata-
racts. The remaining eyes had mixed cataract morphol-
ogy and were excluded from the analysis. Because of the
low number of eyes with cortical cataract, it was not pos-
sible to correlate visual symptoms with LOCS III grad-
ing in this group. In the nuclear cataract group, no sta-
tistically significant correlations were found with visual
symptoms. In the posterior subcapsular cataract group,
a statistically significant correlation was found with the
symptom of blurred vision (rs = 0.420, P = .04). For all
other comparisons, no statistically significant correla-
tions were found.
COMMENT
In this study, UDVA and CDVA improved significantly
in all cataract surgery groups. However, visual acuity is
a crude assessment of visual quality and does not pro-
vide information about visual quality in real-life situa-
tions under different lighting conditions, such as bright
sunlight or oncoming car headlights when driving at
night.16,17 This study found an improvement in subjec-
tive quality of vision after cataract surgery in patients un-
dergoing first and second eye surgery, with or without
ocular comorbidity, with no statistically significant dif-
ferences in the improvement among the 4 groups. Most
important, the preoperative level of visual symptoms ex-
perienced and postoperative improvement in quality of
vision are similar whether patients have unilateral or bi-
lateral cataract and whether they have ocular comorbid-
ity or not. These improvements in quality of vision are
in line with improvements using quality of life scores and
visual functioning after cataract surgery, which may in-
dicate a relationship between these latent traits.18 De-
spite an overall large sample size, the sample sizes are
smaller within each group, which indicates a limitation
of the study. Assuming the same differences found here,
sample sizes of 4921 in each group would be required to
find differences due to ocular comorbidity, with much
larger samples required to find differences between first
and second eye results (80% power, type I error of .001
to account for multiple comparisons). This finding il-
lustrates that there is no clinical significance between these
groups. These findings are important because they dem-
onstrate that the benefit of cataract surgery from the pa-
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Figure. Box plot of Quality of Vision (Qov) questionnaire scores before and 3 months after cataract surgery in patients with or without ocular comorbidity. Boxes
represent the 25th to 75th percentile; black lines within boxes, median; and error bars, ranges.
Table 3. Mean (95% CI) Improvement in QoV Scores in Each of the 4 Groups of Patientsa
Variable
First Eye Second Eye
Without Comorbidity With Comorbidity Without Comorbidity With Comorbidity
Frequency QoV score 22.4 (16.8-28.0) 18.8 (8.6-29.0) 20.0 (13.9-26.1) 17.9 (8.3-27.5)
Severity QoV score 18.3 (13.3-23.3) 16.1 (7.5-24.7) 18.4 (13.0-23.8) 14.2 (6.0-22.4)
Bothersome QoV score 18.3 (12.6-24.0) 15.0 (6.2-23.8) 19.7 (13.5-25.9) 15.3 (5.6-25.0)
Abbreviations: QoV, Quality of Vision.
aAll values are significant at P  .05.
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tient’s perspective of symptom relief is comparable for
all 4 situations. It is therefore possible that the thresh-
old for surgery could be lowered and offered to patients
with unilateral cataract or ocular comorbidity as readily
as it is offered to patients with bilateral cataract and no
ocular comorbidity. Additional shortcomings of this study
are that only monofocal IOLs were assessed and the in-
creasingly common multifocal and toric IOLs were not
assessed.19
The extent of symptoms reported in patients with cata-
racts makes for an interesting comparison with those seen
in refractive surgery. For example, in patients undergo-
ing second eye cataract surgery without ocular comor-
bidity, the median frequency of visual symptoms im-
proved from 41 (range, 90) to 0 (range, 72). A recent
study20 investigating quality of vision using the QoV ques-
tionnaire after laser-assisted subepithelial keratectomy
(LASEK) found the median frequency of symptoms at
postoperative intervals of 5 days, 2 weeks, 1 month, and
3 months to be 72 (range, 90), 52 (range, 72), 0 (range,
45), and 0 (range, 25), respectively. These comparisons
suggest that quality of vision 3 months after the second
eye cataract surgery is similar to 1 month after LASEK.
In addition, the quality of vision in the first 2 weeks af-
ter LASEK is as poor or worse than with cataract. Visual
symptoms have also been reported after cataract sur-
gery and monofocal IOL implantation by other au-
thors.16,21-23 In this study, cataract patients had their re-
sidual refraction corrected with spectacles. Spectacles
alone may induce visual symptoms secondary to factors
such as lens refractive index, base curve, and antireflec-
tive coatings.24,25
A secondary aim of this study was to investigate the
correlation between preoperative LOCS III grading of cata-
ract with the 10 visual symptoms of the QoV question-
naire frequency subscale. Overall, results indicated no
significant correlations between signs and symptoms ex-
cept for one comparison: posterior subcapsular cata-
racts were correlated with the visual symptom of blurred
vision (rs = 0.420). A poor correlation was also found be-
tween the change in CDVA and the change in QoV scores.
Our findings of a poor correlation between signs and
symptoms are in line with previous cataract studies that
compared different variables26,27 and are consistent with
previous research that found that posterior subcapsular
cataracts cause disproportionately more visual disabil-
ity than nuclear or cortical cataracts.28,29 Vasavada et al30
found that patients with posterior subcapsular cataracts
experience reduced vision and not glare, despite objec-
tive glare disability being more common in posterior sub-
capsular cataracts than nuclear or cortical cataract.31 Bin-
ocularity may be a significant confounder of this
relationship because perception of visual symptoms will
consist of the complexities of using both eyes together,
not just the eye undergoing surgery. Eye dominance and
strength of dominance and ocular comorbidity are also
likely to be confounders.32,33 In addition, the use of LOCS
III may be problematic because the decimal grading pro-
vides an illusion to a linear measurement; however, evi-
dence of the linearity of the relationship is lacking and
would impair the correlation with other variables. Ob-
jective cataract grading, such as lens densitometry, may
have yielded better correlations. Most patients in this study
had relatively advanced cataract, and it is hypothesized
that less dense cataract may cause more subtle visual
symptoms and hence provide better correlations.
In conclusion, this study found an improvement in
subjective quality of vision after cataract surgery in pa-
tients undergoing first or second eye surgery, with or with-
out ocular comorbidity, and similar improvements oc-
curred in all 4 groups. In general, poor correlations were
found between cataract morphology and visual symp-
toms with the exception of the correlation found be-
tween blurred vision and posterior subcapsular cata-
racts. Patient-reported outcomes, such as the QoV
questionnaire, are becoming important in the assess-
ment of preoperative and postoperative cataract pa-
tients. Such questionnaires are likely to become an es-
sential tool in general practice and in the clinical
evaluation of new IOLs.
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